Emerging Therapies in Alopecia Areata for Dermatologists - United States

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

The landscape of treatment for Alopecia Areata is advancing, with more evidence and potential breakthrough therapeutic options available to patients. Through this RFP it is our intent to support educational projects that focus on addressing knowledge and practice gaps specific to the recognition, diagnosis, treatment, and overall care management of Alopecia Areata (AA).

Projects that will be considered for Pfizer support should focus on increasing the knowledge and understanding of: 1) Pathophysiology of AA with specific focus on JAK/TEC pathways 2) Epidemiology of the disease, including an understanding of the risk factors 3) Understanding the clinical manifestation of AA, including a holistic review of the burden of disease (e.g. psychosocial burden and associated autoimmune disorders) 4) Which patients require systemic therapies 5) Emerging therapies for AA, such as JAK/TEC inhibitors 6) Place in treatment of current treatment options and upcoming systemic therapies.

Grant Application due date: September 28, 2021

Agency Website

Eligibility Requirements

Geographic Scope: United States

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.



Amount Description

Individual projects requesting up to $250,000 will be considered.

Funding Type





Curriculum Development
Medical - Clinical Science

External Deadline

September 28, 2021